Joseph Miller
Director of Finance/CFO chez AURINIA PHARMACEUTICALS INC.
Fortune : 2 M $ au 31/03/2024
Profil
Joseph M.
Miller is currently the Chief Financial Officer at Aurinia Pharmaceuticals, Inc. He previously worked as the Senior Director-Accounting at Qiagen Genomics, Inc. from 2006 to 2015.
From 2018 to 2022, he served as the Director at Avalo Therapeutics, Inc. Prior to that, he was the Vice President-Finance at Sucampo Pharmaceuticals LLC from 2015 to 2018.
Mr. Miller also held the position of Chief Financial Officer & Vice President-Finance at Eppendorf-5 Prime, Inc. from 2002 to 2006.
He obtained his undergraduate degree from Villanova University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 06/03/2024 | 495 928 ( 0,34% ) | 2 M $ | 31/03/2024 |
Postes actifs de Joseph Miller
| Sociétés | Poste | Début |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Director of Finance/CFO | 27/04/2020 |
Anciens postes connus de Joseph Miller
| Sociétés | Poste | Fin |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 24/04/2020 |
| SUCAMPO PHARMACEUTICALS, INC. | Director of Finance/CFO | 01/04/2018 |
Qiagen Genomics, Inc.
 Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Comptroller/Controller/Auditor | 01/01/2015 |
| Eppendorf-5 Prime, Inc. | Director of Finance/CFO | 01/01/2006 |
Formation de Joseph Miller
| Villanova University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AVALO THERAPEUTICS, INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Qiagen Genomics, Inc.
Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Eppendorf-5 Prime, Inc. |
